Inflammation as potential target for therapy to target residual risk post ACS.
29 August 2016 (12:55 - 13:10)
Organised by:
About the speaker
Brigham and Women's Hospital, Boston (United States of America)
4 More presentations in this session
Professor C. Packard (Glasgow, GB)
Professor E. Stroes (Amsterdam, NL)
Professor P. Libby (Boston, US)
Professor J. Deanfield (London, GB)
Access the full session
The Event
ESC Congress 2016
29 August 2016
12:55 CET
You may be interested in
Congress Presentation
Congress Session
Congress Presentation
Congress Presentation
